hydralazine has been researched along with Erythroblastosis Fetalis in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DEMARCO, P | 1 |
| SHOHOV, P | 1 |
| KRESKY, B | 1 |
| ZAINO, EC | 1 |
1 other study available for hydralazine and Erythroblastosis Fetalis
| Article | Year |
|---|---|
DISSEMINATED LUPUS ERYTHEMATOSUS IN A 28-MONTH-OLD INFANT WITH ONSET DURING HYDRALAZINE THERAPY.
Topics: Blood Transfusion; Cerebral Palsy; Child; Diseases in Twins; Erythroblastosis, Fetal; Fetus; Hydrala | 1964 |